Nearly 600 cell lines commonly used in biomedical research today are misidentified or cross-contaminated, according to a recent paper and several additional studies. One estimates that nearly 33,000 studies have…
Planarian flatworms pictured in the Stowers Institute’s planarian facility. A recent discovery from Stowers scientists may help explain the flatworm’s extraordinary ability to regenerate—and could offer clues for developing new…
Ankylosing Spondylitis (AS) is a debilitating, immune-mediated disease which causes inflammation of the joints between the vertebrae, leading to stiffness, pain, and eventually fusion of the spine. The underpinnings of…
With its pipeline expanding beyond its initial focus on in vivo programming of myeloid cells, for which the company took its initial name, Myeloid Therapeutics has rebranded as Create Medicines…
Credit: Steve Gschmeissner/Science Photo Library/Getty Images An international study led by scientists at Flinders University and at South China University of Technology has uncovered a new vulnerability in prostate cancer…
Credit: Recipharm Recipharm, a CDMO, opened its newly-commissioned parenteral development and sterility laboratories at its Bengaluru site in India. The parenteral development laboratory is designed to accelerate the development of…
Blood smear of chronic lymphocytic leukemia. Cancer doesn’t follow a linear path—it evolves, adapts, and forks. Even within a single tumor, individual cells behave differently. They mutate, diverge, and form…
SEATTLE – “Proteins are these beautiful and strange mysteries of nature,” described Nobel Laureate, David Baker, PhD, to an audience of fundraiser donors at the Amazon Meeting Center in downtown…
KPMG recently released its 2025 U.S. CEO Outlook. A critical section of the survey, which took place in September, explored the views of over 100 life sciences CEOs to assess…
If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes with its…